SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-16-026763
Filing Date
2016-11-01
Accepted
2016-11-01 17:22:55
Documents
3
Period of Report
2016-10-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ITEM 5.02 APPOINTMENT OF PRINCIPAL OFFICERS atrs-8k_20161031.htm 8-K 51996
2 EX-99.1 PRESS RELEASE atrs-ex991_6.htm EX-99.1 16912
3 GRAPHIC g201611012023019648579.jpg GRAPHIC 17898
  Complete submission text file 0001564590-16-026763.txt   95264
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 161965672
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10